Inhibikase Therapeutics Market Sentiment

Inhibikase Therapeutics Inc

IKTNASDAQ

$1.83

0.031.67%

Inhibikase Therapeutics Market Sentiment - Benzinga

Market sentiment signals for Inhibikase Therapeutics (IKT): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▼ 21.7% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

9 analysts

Options Flow (P/C)

—

Avg Consensus PT

+174.4%

Highest Price Target

+344.4%

Jefferies

Lowest Price Target

-16.7%

Chardan Capital

Short Interest

21.7%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 13, 2026	Chardan Capital	Andreas Argyrides—	-16.7%	$2	Initiate	Neutral
Jun 10, 2026	Oppenheimer	——	+177.8%	$5	Initiate	Outperform
Mar 4, 2026	Ladenburg Thalmann	Aydin Huseynov—	+122.2%	$4	Initiate	Buy
Jan 21, 2026	B of A Securities	Jason Zemansky—	+233.3%	$6	Initiate	Buy
Dec 26, 2025	HC Wainwright & Co.	Raghuram Selvaraju—	+344.4%	$8	Assumes	Buy
Dec 17, 2025	Freedom Broker	Ilya Zubkov—	+66.7%	$3	Initiate	Buy
Dec 11, 2025	Cantor Fitzgerald	Olivia Brayer—	+122.2%	$4	Initiate	Overweight
Mar 28, 2025	HC Wainwright & Co.	Edward White—	—	—	Maintained	Neutral
Feb 12, 2025	HC Wainwright & Co.	Edward White—	—	—	Downgrade	Buy→Neutral
Nov 8, 2024	Jefferies	Dennis Ding—	+344.4%	$8	Initiate	Buy
Oct 14, 2024	HC Wainwright & Co.	Edward White—	+177.8%	$15 → $5	Maintained	Buy
Aug 16, 2024	HC Wainwright & Co.	Edward White—	+733.3%	$23 → $15	Maintained	Buy
May 21, 2024	HC Wainwright & Co.	Edward White—	+1177.8%	$27 → $23	Maintained	Buy
Mar 7, 2024	HC Wainwright & Co.	Edward White—	+1400.0%	$27 → $27	Maintained	Buy
Mar 5, 2024	HC Wainwright & Co.	Edward White—	+1400.0%	$27 → $27	Maintained	Buy